Therapeutic Inertia and the Medicare Crisis

Inercia terapéutica en pacientes hipertensos asistidos en atención primaria en España. Estudio Objetivo Kontrol

“…En definitiva, la actitud del médico de AP, en la muestra estudiada, ante el mal control de la HTA es poco rigurosa según las recomendaciones de las GPC. De acuerdo con otros autores 5,17 , las causas y posibles soluciones a la IT son variadas. La formación adecuada, el reconocimiento de la situación actual del problema, la optimización de las condiciones de trabajo e incluso la motivación del médico mediante incentivos, como se ha demostrado recientemente en el Reino Unido 18 , pueden contribuir decisivamente en la mejora del control de la HTA en nuestro país.…”

Enhancing Dosage Flexibility in Combination Therapy

“…Combination drug therapy of hypertension has become more widely used to achieve the lower blood pressure goals currently recommended, especially for patients with diabetes mellitus and chronic kidney disease. When fixed‐dose combination products are used, there may be an additional disincentive to perform drug dose titration when indicated because of what has been termed clinical inertia or therapeutic inertia 7,8 . This is the result, in part, of the need to write a new prescription for a higher dose combination product and the possible lack of flexibility of dose forms.…”

Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension

“…The problem of 'therapeutic inertia' has been increasingly recognized in clinical and observational studies, especially in the management of chronic diseases such as diabetes and hypertension [5][6][7][8][9]. Therapeutic inertia is defined as the failure of clinicians to initiate or intensify therapy when treatment goals are unmet [6].…”